Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1012493 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Gang Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, Virus Internalization, Epitopes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Grasping the roles of epitopes in viral glycoproteins is essential for unraveling the structure and function of these proteins. Up to now, all identified epitopes have been found to either neutralize, have no effect on, or enhance viral entry into cells. Here, we used nanobodies (single-domain antibodies) as probes to investigate a unique epitope on the SARS-CoV-2 spike protein, located outside the protein’s receptor-binding domain. Nanobody binding to this epitope enhances the cell entry of prototypic SARS-CoV-2, while neutralizing the cell entry of SARS-CoV-2 Omicron variant. Moreover, nanobody binding to this epitope promotes both receptor binding activity and post-attachment activity of prototypic spike, explaining the enhanced viral entry. The opposite occurs with Omicron spike, explaining the neutralized viral entry. This study reveals a unique epitope that can both enhance and neutralize viral entry across distinct viral variants, suggesting that epitopes may vary their roles depending on the viral context. Consequently, antibody therapies should be assessed across different viral variants to confirm their efficacy and safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.
- Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota, United States of America.
- Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.
- Center for Predictive Medicine, University of Louisville, Louisville, Kentucky, United States of America.
- Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky, United States of America.
- Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America.
ORCID-Profile: Fang Li
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Ye, G., Bu, F., Pan, R., Mendoza, A., Saxena, D., Zheng, J., Perlman, S., Liu, B., & Li, F. (2024). Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012493
Vancouver
Ye G, Bu F, Pan R, Mendoza A, Saxena D, Zheng J, et al. Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1012493
BibTeX
@article{Ye2024,
author = {Ye, Gang and Bu, Fan and Pan, Ruangang and Mendoza, Alise and Saxena, Divyasha and Zheng, Jian and Perlman, Stanley and Liu, Bin and Li, Fang},
title = {Dual-role epitope on SARS-CoV-2 spike enhances and neutralizes viral entry across different variants},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1012493}
}
EUVIMED